Navigation Links
Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
Date:4/23/2012

d based on their baseline cervical motor level of sensori motor complete spinal cord injury (ASIA Impairment Scale A, with a C4 to C7 level of cord injury) and will be stratified according to the baseline cervical motor level.

"SUN13837 is expected to provide neuroprotection from glutamate excito-toxicity and promote axonal outgrowth, which is often inhibited after spinal cord injury," said Benjamin Levinson, M.D., Senior Director of Medical and Scientific Affairs at Asubio. "It is similar in mechanism to basic fibroblast growth factor (bFGF) but without the troublesome complication of stimulating cell proliferation. Like bFGF, SUN13837 is thought to bind with FGF receptors to induce the intracellular signaling events providing its positive properties.  Unlike bFGF (a large protein), SUN13837 is a highly lipid soluble small molecule that can be easily and reliably administered through peripheral intravenous injection."

SUN13837 has been without significant side effects in Phase 1 studies in healthy subjects. Experimental evidence has shown SUN13837 to have both neuroprotective and axonal outgrowth properties using both invitro studies and animal models of spinal cord injury.  In these models, SUN13837 administration improved corticospinal neuron survival and axonal regrowth, resulting in statistically significant functional recovery relative to placebo.  The preclinical evidence supports the concept that potential drug benefits will be due to 1) neuroprotection by limiting the degree of primary mechanical damage at the injury site, 2) augmentation of axonal outgrowth in the otherwise unfavorable post-injury microenvironment, and 3) facilitation of functional neural plasticity within surviving and newly formed neural circuits.

"A two motor-level improvement in a mid-cervical injury can have a significant impact for improving a patient's activities of daily living, including self-care and mobility according to a recent publ
'/>"/>

SOURCE Asubio
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
2. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
6. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
7. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. Prolexys Pharmaceuticals Initiates Phase 1 Study
10. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
11. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 Cynosure, Inc. (NASDAQ: ... for non-invasive and minimally invasive applications, today announced that the ... Officer and Chief Financial Officer Timothy W. Baker ... 53, will continue to serve as CFO and will take ... remains Chairman and Chief Executive Officer. "Tim ...
(Date:7/30/2014)... N.J. and SAN DIEGO , ... (NASDAQ: ARNA ) announced today that an article ... trials of lorcaserin entitled, "Early Weight Loss While on Lorcaserin, ... Outcomes," was recently published in the online issue of ... Society. The objective of these analyses was to identify whether ...
(Date:7/30/2014)... /PRNewswire-iReach/ -- This is a professional and in-depth ... (CAS 9041-08-1) & calcium (CAS 37270-89-6) industry. The ... sodium (CAS 9041-08-1) & calcium (CAS 37270-89-6) including ... then explores global and China,s top manufacturers of ... listing their product specification, capacity, production value, cost, ...
Breaking Medicine Technology:Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 2Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 4Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 5
... , ST. LOUIS, Jan. 11 KV Pharmaceutical Company ... the existing asset purchase agreement with Hologic, Inc. to secure the ... and conditions set forth in the amendment. Upon approval by the ... first and only FDA-approved treatment for the prevention of preterm birth ...
... N.J., Jan. 11 Survival of the fittest? In ... only what you know today, but what you need to ... has the right insight and accurate forecasting skills will excel. ... growing) market in the world, its sheer size also presents ...
Cached Medicine Technology:KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM) 2KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM) 3KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM) 4KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM) 5KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM) 6KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM) 7Elite Pharma Insiders to Reveal Key Survival Strategies for Pharmaceutical Industry in 2010 2
(Date:7/30/2014)... LTC Consumer, an independent, free online service to help ... Instant Quote tool on its website, LTCconsumer.com , announced ... are free and unlimited. , The Instant Quote tool ... including age, gender, and state of residence – and delivers ... to enter any contact information to get started). There is ...
(Date:7/30/2014)... Washington, DC (PRWEB) July 30, 2014 ... its appreciation to U.S. Sens. Thad Cochran (R-MS) ... push for improvements in telemedicine coverage under Medicare, ... Cochran and Wicker, both Mississippi Republicans, introduced the ... bill to a House version, H.R. 3306, introduced ...
(Date:7/30/2014)... 2014 Hospitals continually face the ... care that their practitioners provide. During a recent ... discussed the importance of establishing effective peer review ... and quality of care. , With regard ... Rowe elaborated on setting performance expectations, conducting regular ...
(Date:7/30/2014)... Bay Aquarium Research Institute (MBARI) have observed a deep-sea ... yearslonger than any other known animal. Throughout this time, ... from predators. This amazing feat represents an evolutionary balancing ... having plenty of time to develop within their eggs, ... little or no food. , Every few months for ...
(Date:7/30/2014)... 30, 2014 Frozen shoulder (Adhesive capsulitis) affects ... to develop this nasty condition which occurs most frequently in ... last up to two and half years if not treated. ... and with good reason: it can render your shoulder so ... is, if you aren't in too much pain to get ...
Breaking Medicine News(10 mins):Health News:LTC Consumer Launches Online Tool for Getting Instant Long Term Care Insurance Estimates 2Health News:ATA Applauds Senators’ Push for Federal Telemedicine Improvements 2Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 2Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 3Health News:Deep-sea octopus broods eggs for over 4 years -- longer than any known animal 2Health News:Deep-sea octopus broods eggs for over 4 years -- longer than any known animal 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 2Health News:Good News for Diabetics Suffering from Frozen Shoulder 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 4
... ANGELES, Oct. 16 D.I.S.C. (Diagnostic and,Interventional Spinal and ... "Official Medical Center" of the N.H.L.,s Los,Angeles Kings hockey ... into the sports marketing arena in a very significant,way. ... natural fit for us and we,are thrilled to be ...
... Surgical,Company (Nasdaq: STAA ) today announced that ... ended September 29, 2007 on Tuesday, October,30, 2007 ... a conference call,and webcast on Tuesday, October 30, ... Company,s third quarter and current corporate developments. The,dial-in ...
... American,Cancer Society (ACS) inaugurated the National Breast Cancer ... Mammography Day. The NBCAM,was conceived and funded by ... petrochemicals, and its U.S. subsidiary,Zeneca Pharmaceuticals. Zeneca is ... of breast cancer, even though it is toxic ...
... While it is commonly thought that men with low ... or sexual deviance, new research has found the men ... sex education previously taken. , A team of ... and without an intellectual disability and a history of ...
... Oct. 16 Expected to be,her family,s Halloween treat, ... 1 pound, 10 ounces. Today, the five-year-old of,Allentown, Pennsylvania ... Catharine, who was born 16 weeks early, measuring only ... than half a million,babies born preterm each year in ...
... More Than,100,000 Kids, WASHINGTON, Oct. 16 As ... that would increase the,state cigarette tax to fund children,s ... increase would not only fund health care for more,than ... and,tobacco-related health care costs and save thousands of lives., ...
Cached Medicine News:Health News:D.I.S.C. Scores First Sponsorship Deal as Official Medical Center of the Los Angeles Kings 2Health News:STAAR Surgical Announces Third Quarter 2007 Earnings Release Date and Conference Call 2Health News:Cancer Prevention Coalition: The Breast Cancer Awareness Month Misleads Women 2Health News:Cancer Prevention Coalition: The Breast Cancer Awareness Month Misleads Women 3Health News:'Corrective' sex education may make sexual offenders more dangerous 2Health News:March of Dimes Selects Pennsylvania Girl as 2008 National Ambassador 2Health News:New Report: Increasing Oregon's Cigarette Tax Will Reduce Smoking, Save Lives and Save Money 2
AST (SGOT) R1 + R2. Automated analyzer test kits....
For the quantitative determination of aspartate aminotransferase (AST) in human serum. The reagents are used in routine examination and monitoring of therapy and relapses....
Intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma. Reaction: Kinetic. Wavelength: 340 nm. Linearity: 268 U/L at 30C. Two vials, dry powder reagents...
Intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma. Reaction: Kinetic. Wavelength: 340 nm. Linearity: 440 U/L at 30C. Single vial, dry powder reagen...
Medicine Products: